115 related articles for article (PubMed ID: 26100671)
1. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
[TBL] [Abstract][Full Text] [Related]
2. Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy.
Powell DJ; Dudley ME; Robbins PF; Rosenberg SA
Blood; 2005 Jan; 105(1):241-50. PubMed ID: 15345595
[TBL] [Abstract][Full Text] [Related]
3. L-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy.
Watson HA; Durairaj RRP; Ohme J; Alatsatianos M; Almutairi H; Mohammed RN; Vigar M; Reed SG; Paisey SJ; Marshall C; Gallimore A; Ager A
Front Immunol; 2019; 10():1321. PubMed ID: 31249570
[TBL] [Abstract][Full Text] [Related]
4. Gamma(c) deficiency precludes CD8+ T cell memory despite formation of potent T cell effectors.
Decaluwe H; Taillardet M; Corcuff E; Munitic I; Law HK; Rocha B; Rivière Y; Di Santo JP
Proc Natl Acad Sci U S A; 2010 May; 107(20):9311-6. PubMed ID: 20439728
[TBL] [Abstract][Full Text] [Related]
5. B cells imprint adoptively transferred CD8
Smith AS; Knochelmann HM; Wyatt MM; Rangel Rivera GO; Rivera-Reyes AM; Dwyer CJ; Ware MB; Cole AC; Neskey DM; Rubinstein MP; Liu B; Thaxton JE; Bartee E; Paulos CM
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017148
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.
Spranger S; Dai D; Horton B; Gajewski TF
Cancer Cell; 2017 May; 31(5):711-723.e4. PubMed ID: 28486109
[TBL] [Abstract][Full Text] [Related]
7. Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors.
Xin G; Schauder DM; Jing W; Jiang A; Joshi NS; Johnson B; Cui W
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):740-745. PubMed ID: 28069963
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Associated Monocytes Reprogram CD8
Yang Z; Liu L; Zhu Z; Hu Z; Liu B; Gong J; Jin Y; Luo J; Deng Y; Jin Y; Wang G; Yin Y
Adv Sci (Weinh); 2024 Apr; 11(16):e2304501. PubMed ID: 38386350
[TBL] [Abstract][Full Text] [Related]
9. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells.
Dong MB; Wang G; Chow RD; Ye L; Zhu L; Dai X; Park JJ; Kim HR; Errami Y; Guzman CD; Zhou X; Chen KY; Renauer PA; Du Y; Shen J; Lam SZ; Zhou JJ; Lannin DR; Herbst RS; Chen S
Cell; 2019 Aug; 178(5):1189-1204.e23. PubMed ID: 31442407
[TBL] [Abstract][Full Text] [Related]
10. CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.
Norell H; Zhang Y; McCracken J; Martins da Palma T; Lesher A; Liu Y; Roszkowski JJ; Temple A; Callender GG; Clay T; Orentas R; Guevara-Patiño J; Nishimura MI
Cancer Immunol Immunother; 2010 Jun; 59(6):851-62. PubMed ID: 20052466
[TBL] [Abstract][Full Text] [Related]
11. Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells.
Qiu F; Jiang P; Zhang G; An J; Ruan K; Lyu X; Zhou J; Sheng W
Nat Commun; 2024 May; 15(1):4327. PubMed ID: 38773088
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8
Wang J; Hasan F; Frey AC; Li HS; Park J; Pan K; Haymaker C; Bernatchez C; Lee DA; Watowich SS; Yee C
Cancer Immunol Res; 2020 Jun; 8(6):794-805. PubMed ID: 32213626
[TBL] [Abstract][Full Text] [Related]
13. MEK inhibition reprograms CD8
Verma V; Jafarzadeh N; Boi S; Kundu S; Jiang Z; Fan Y; Lopez J; Nandre R; Zeng P; Alolaqi F; Ahmad S; Gaur P; Barry ST; Valge-Archer VE; Smith PD; Banchereau J; Mkrtichyan M; Youngblood B; Rodriguez PC; Gupta S; Khleif SN
Nat Immunol; 2021 Jan; 22(1):53-66. PubMed ID: 33230330
[TBL] [Abstract][Full Text] [Related]
14. Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.
Klebanoff CA; Scott CD; Leonardi AJ; Yamamoto TN; Cruz AC; Ouyang C; Ramaswamy M; Roychoudhuri R; Ji Y; Eil RL; Sukumar M; Crompton JG; Palmer DC; Borman ZA; Clever D; Thomas SK; Patel S; Yu Z; Muranski P; Liu H; Wang E; Marincola FM; Gros A; Gattinoni L; Rosenberg SA; Siegel RM; Restifo NP
J Clin Invest; 2016 Jan; 126(1):318-34. PubMed ID: 26657860
[TBL] [Abstract][Full Text] [Related]
15. Understanding memory CD8
Samji T; Khanna KM
Immunol Lett; 2017 May; 185():32-39. PubMed ID: 28274794
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+ T cells.
Chaudhuri L; Srivastava RK; Kos F; Shrikant PA
Cancer Immunol Immunother; 2016 Jul; 65(7):869-74. PubMed ID: 27271549
[TBL] [Abstract][Full Text] [Related]
17. cBAF complex components and MYC cooperate early in CD8
Guo A; Huang H; Zhu Z; Chen MJ; Shi H; Yuan S; Sharma P; Connelly JP; Liedmann S; Dhungana Y; Li Z; Haydar D; Yang M; Beere H; Yustein JT; DeRenzo C; Pruett-Miller SM; Crawford JC; Krenciute G; Roberts CWM; Chi H; Green DR
Nature; 2022 Jul; 607(7917):135-141. PubMed ID: 35732731
[TBL] [Abstract][Full Text] [Related]
18. Role of T and NK cells and IL7/IL7r interactions during neonatal maturation of lymph nodes.
Coles MC; Veiga-Fernandes H; Foster KE; Norton T; Pagakis SN; Seddon B; Kioussis D
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13457-62. PubMed ID: 16938836
[TBL] [Abstract][Full Text] [Related]
19. Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy.
Han J; Zhao Y; Shirai K; Molodtsov A; Kolling FW; Fisher JL; Zhang P; Yan S; Searles TG; Bader JM; Gui J; Cheng C; Ernstoff MS; Turk MJ; Angeles CV
Nat Cancer; 2021 Mar; 2(3):300-311. PubMed ID: 34179824
[TBL] [Abstract][Full Text] [Related]
20. IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models.
Yu J; Gadwa J; Ross RB; Knitz M; Darragh LB; Abdelazeem KNM; Beynor J; Neupert B; Nguyen A; Nguyen D; Olimpo N; Corbo S; Van Court B; D'Alessandro A; Saviola A; Karam SD
Cancer Immunol Immunother; 2024 Mar; 73(5):90. PubMed ID: 38554147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
